초음파 프로브 소독 시장 : 점유율 분석, 업계 동향과 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, ultrasound probe disinfection market size in 2026 is estimated at USD 820 million, growing from 2025 value of USD 729 million with 2031 projections showing USD 1.44 billion, growing at 11.93% CAGR over 2026-2031.

This report is Segmented by Product (Instruments, Consumables, and Services), Process (Intermediate/Low-level Disinfection and High-Level Disinfection), Technology (Hydrogen-Peroxide Mist, UV-C Light, and More), Probe Type (Linear Transducers, and More), End User (Hospitals & Diagnostic Laboratories, and More), and Geography. The Market Forecasts are Provided in Terms of Value (USD).

Global Ultrasound Probe Disinfection Market Trends and Insights

Rising Ultrasound Imaging Procedure Volumes

Global ultrasound utilization continues to soar as physicians broaden applications across emergency, critical-care, and musculoskeletal disciplines. Point-of-care adoption allows clinicians to scan at the bedside, compressing diagnostic timelines and lifting procedural counts. In low- and middle-income countries, 80% of providers surveyed rated ultrasound access as essential to improving care quality.Portable, battery-powered scanners expand outreach clinics but introduce mobile disinfection challenges, thereby magnifying demand for quick-cycling, countertop units. Health ministries are bundling probe reprocessors into national imaging upgrades to guarantee infection control parity with advanced economies. As procedure volumes climb, every incremental scan increases the risk of cross-contamination, reinforcing the ultrasound probe disinfection market's growth trajectory.

Escalating Incidence & Penalties For Hospital-Acquired Infections (HAIs)

Governments and private insurers impose financial penalties on facilities that exceed HAI benchmarks, and contaminated probes remain a documented vector. A multicenter study showed over 90% of transvaginal probes harbored pathogens after low-level wipes, evidencing shortfalls in legacy cleaning workflows. The CDC's 2025 health alert on gel-borne Paraburkholderia fungorum infections renewed scrutiny of sonography suites. Hospitals now calculate potential fines plus reputational damage when budgeting for automated cabinets. Cost analyses reveal damaged transesophageal probes can add USD 1,800-USD 9,000 in repair charges, often precipitated by improper manual cleaning. Consequently, facilities fast-track investments that standardize disinfection cycles and log proof of compliance.

High Capital Cost Of Automated Reprocessors

Automated cabinets can exceed USD 25,000 each, a hurdle for rural hospitals and budget-constrained clinics. Nanosonics noted that tight capital budgets slowed new placements early in fiscal 2024, although second-half orders rebounded 14% as purchasing cycles normalized. Total cost of ownership extends to consumable cartridges and annual service contracts, stretching limited budgets. Facilities in markets where infection-prevention investments lack direct reimbursement must reconcile the up-front outlay with longer-term savings from fewer HAIs and lower labor costs. Until financing programs or pay-for-prevention incentives mature, adoption may lag in cash-strapped settings, tempering the ultrasound probe disinfection market's upside.

Other drivers and restraints analyzed in the detailed report include:

1. Regulatory Mandates For High-Level Disinfection Of Semi-Critical Probes
2. Rapid Adoption Of Automated HLD Systems & UV-C Cabinets
3. Low Awareness & Training Gaps In Low- And Mid-Income Facilities

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Consumables controlled 48.62% of 2025 revenue as facilities restock disinfectant cartridges, probe covers, and filters daily. Services, however, are projected to pace the ultrasound probe disinfection market at a 13.76% CAGR through 2031 as hospitals outsource maintenance, calibration, and compliance audits. The shift mirrors broader healthcare moves toward outcome-based contracting, where vendors guarantee uptime and accreditation readiness rather than selling stand-alone kits.

Some health systems bundle training, software updates, and remote diagnostics into multiyear service plans that spread cost and free internal staff. Nanosonics added 2,340 units in fiscal 2024, reaching 34,790 global installations, which feed a recurring revenue stream of consumables and digital monitoring fees. Providers value rapid support that avoids exam cancellations, reinforcing service uptake across the ultrasound probe disinfection industry.

High-level disinfection accounted for 60.05% share of the ultrasound probe disinfection market size in 2025 and will outpace other processes at a 12.98% CAGR as regulators tighten rules on semi-critical devices. Spaulding classification places endocavitary probes squarely in the high-level category, and compliance audits increasingly flag any deviation.

Intermediate and low-level wipes remain permissible for surface scans on intact skin, but many hospitals standardize on high-level cycles to simplify staff training and limit error. Automated logs that record temperature, concentration, and exposure times help clinicians demonstrate adherence to FDA and CE guidance. Over the forecast horizon, multi-tiered protocols may give way to single high-level standards that protect all patients equally, driving steady gains for the segment.

Complete Report Scope:

• By Product
  • Instruments
  • Consumables
  • Services
• By Process
  • Intermediate / Low-level Disinfection
  • High-level Disinfection
• By Technology
  • Hydrogen-Peroxide Mist
  • UV-C Light
  • Ozone-based
  • Chlorine-Dioxide & Other Chemicals
• By Probe Type
  • Linear Transducers
  • Convex Transducers
  • Phased-Array Transducers
• By End User
  • Hospitals & Diagnostic Laboratories
  • Ambulatory Care Centers
  • Research & Academic Institutes
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America led the ultrasound probe disinfection market with 36.45% of global revenue in 2025, underpinned by FDA mandates, insurer penalties for HAIs, and capital budgets that prioritize automated HLD cabinets. Hospitals routinely integrate RFID-enabled reprocessors with electronic health records, streamlining Joint Commission audits and reinforcing best-practice diffusion across the region. The mature reimbursement climate offsets high device costs, allowing health systems to adopt premium chemical-free units rapidly.

Europe remains a substantial contributor, leveraging CE harmonization to expedite technology circulation across member states. Environmental regulations encourage migration to UV-C systems that avoid chemical disposal, and procurement frameworks increasingly weigh life-cycle sustainability metrics. Cross-border hospital groups standardize preferred vendor lists, giving compliant suppliers pan-regional scale. Meanwhile, national infection-prevention action plans push smaller clinics to match the standards of flagship university hospitals, enriching the total addressable market.

Asia Pacific is forecast to post a 14.22% CAGR as China, India, and Southeast Asian nations pour funds into imaging capacity and infection-control modernization. Government insurance schemes finance rural ultrasound deployment, frequently stipulating high-level disinfection capabilities to curb cross-infection risks. Domestic manufacturers in China and South Korea introduce cost-effective peroxide cabinets, raising competitive stakes. Emerging regions in MEA and Latin America continue to upgrade basic disinfection infrastructure, but financing gaps and supply-chain volatility temper near-term momentum.

1. Nanosonics
2. CIVCO Medical solutions
3. Tristel
4. Germitec
5. Ecolab
6. Advanced Sterilization Products (ASP)
7. CS Medical LLC
8. Metrex Research
9. Soluscope
10. Virox Technologies
11. Parker Laboratories
12. Cantel Medical
13. Steris plc
14. Whiteley Corporation
15. Borer Chemie
16. Lanxess AG
17. TSO3 Inc.
18. BluLine Solutions
19. Cleanis SAS

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rising Ultrasound Imaging Procedure Volumes
  • 4.2.2 Escalating Incidence & Penalties For Hospital-Acquired Infections (Hais)
  • 4.2.3 Regulatory Mandates For High-Level Disinfection Of Semi-Critical Probes
  • 4.2.4 Rapid Adoption Of Automated HLD Systems & UV-C Cabinets
  • 4.2.5 Expiry Of Core HLD Device Patents Opening Mid-Tier Competition
  • 4.2.6 Integration Of RFID/Iot Traceability Boosting Purchasing Decisions
• 4.3 Market Restraints
  • 4.3.1 High Capital Cost Of Automated Reprocessors
  • 4.3.2 Low Awareness & Training Gaps In Low- And Mid-Income Facilities
  • 4.3.3 Hydrogen-Peroxide-Supply Chain Constraints In Emerging Nations
  • 4.3.4 Threat Of Single-Use Sterile Probe Covers Substituting Reprocessing
• 4.4 Value / Supply-Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technology Outlook
• 4.7 Porter's Five Forces Analysis
  • 4.7.1 Bargaining Power of Suppliers
  • 4.7.2 Bargaining Power of Buyers
  • 4.7.3 Threat of New Entrants
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Intensity of Competitive Rivalry

5 Market Size and Growth Forecasts (Value-USD)

• 5.1 By Product
  • 5.1.1 Instruments
  • 5.1.2 Consumables
  • 5.1.3 Services
• 5.2 By Process
  • 5.2.1 Intermediate / Low-level Disinfection
  • 5.2.2 High-level Disinfection
• 5.3 By Technology
  • 5.3.1 Hydrogen-Peroxide Mist
  • 5.3.2 UV-C Light
  • 5.3.3 Ozone-based
  • 5.3.4 Chlorine-Dioxide & Other Chemicals
• 5.4 By Probe Type
  • 5.4.1 Linear Transducers
  • 5.4.2 Convex Transducers
  • 5.4.3 Phased-Array Transducers
• 5.5 By End User
  • 5.5.1 Hospitals & Diagnostic Laboratories
  • 5.5.2 Ambulatory Care Centers
  • 5.5.3 Research & Academic Institutes
• 5.6 By Geography
  • 5.6.1 North America
    • 5.6.1.1 United States
    • 5.6.1.2 Canada
    • 5.6.1.3 Mexico
  • 5.6.2 Europe
    • 5.6.2.1 Germany
    • 5.6.2.2 United Kingdom
    • 5.6.2.3 France
    • 5.6.2.4 Italy
    • 5.6.2.5 Spain
    • 5.6.2.6 Rest of Europe
  • 5.6.3 Asia-Pacific
    • 5.6.3.1 China
    • 5.6.3.2 Japan
    • 5.6.3.3 India
    • 5.6.3.4 Australia
    • 5.6.3.5 South Korea
    • 5.6.3.6 Rest of Asia-Pacific
  • 5.6.4 Middle East and Africa
    • 5.6.4.1 GCC
    • 5.6.4.2 South Africa
    • 5.6.4.3 Rest of Middle East and Africa
  • 5.6.5 South America
    • 5.6.5.1 Brazil
    • 5.6.5.2 Argentina
    • 5.6.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products and Services, and Recent Developments)
  • 6.3.1 Nanosonics
  • 6.3.2 CIVCO Medical Solutions
  • 6.3.3 Tristel plc
  • 6.3.4 Germitec
  • 6.3.5 Ecolab
  • 6.3.6 Advanced Sterilization Products (ASP)
  • 6.3.7 CS Medical LLC
  • 6.3.8 Metrex Research LLC
  • 6.3.9 Soluscope
  • 6.3.10 Virox Technologies
  • 6.3.11 Parker Laboratories
  • 6.3.12 Cantel Medical
  • 6.3.13 Steris plc
  • 6.3.14 Whiteley Corporation
  • 6.3.15 Borer Chemie AG
  • 6.3.16 Lanxess AG
  • 6.3.17 TSO3 Inc.
  • 6.3.18 BluLine Solutions
  • 6.3.19 Cleanis SAS

7 Market Opportunities and Future Outlook

• 7.1 White-Space and Unmet-Need Assessment